SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,368 | +1088.3% | 11,990 | +1600.7% | 0.00% | – |
Q2 2023 | $7,184 | +4564.9% | 705 | -95.8% | 0.00% | -100.0% |
Q1 2023 | $154 | +48.1% | 16,982 | +17.5% | 0.01% | +25.0% |
Q4 2022 | $104 | -99.8% | 14,449 | +80.3% | 0.00% | +300.0% |
Q3 2022 | $52,000 | +67.7% | 8,016 | +23.4% | 0.00% | 0.0% |
Q2 2022 | $31,000 | +3000.0% | 6,496 | +6396.0% | 0.00% | – |
Q1 2022 | $1,000 | -92.3% | 100 | -95.3% | 0.00% | – |
Q2 2021 | $13,000 | -27.8% | 2,112 | -22.7% | 0.00% | – |
Q1 2021 | $18,000 | -5.3% | 2,733 | -22.8% | 0.00% | -100.0% |
Q4 2020 | $19,000 | -53.7% | 3,540 | -36.3% | 0.00% | – |
Q3 2020 | $41,000 | -50.6% | 5,555 | -50.6% | 0.00% | -100.0% |
Q2 2020 | $83,000 | +591.7% | 11,240 | +602.1% | 0.00% | +200.0% |
Q1 2020 | $12,000 | +200.0% | 1,601 | +151.3% | 0.00% | – |
Q4 2019 | $4,000 | -60.0% | 637 | -80.2% | 0.00% | -100.0% |
Q2 2019 | $10,000 | -54.5% | 3,211 | -56.9% | 0.00% | 0.0% |
Q1 2019 | $22,000 | +450.0% | 7,446 | +625.7% | 0.00% | – |
Q4 2018 | $4,000 | +100.0% | 1,026 | +273.1% | 0.00% | – |
Q3 2018 | $2,000 | -75.0% | 275 | -80.8% | 0.00% | – |
Q2 2018 | $8,000 | – | 1,430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
5AM Venture Management, LLC | 3,831,474 | $23,410,000 | 5.89% |
AIGH Capital Management LLC | 642,154 | $3,924,000 | 0.71% |
Ikarian Capital, LLC | 1,095,024 | $6,690,000 | 0.54% |
Worth Venture Partners, LLC | 163,994 | $1,002,000 | 0.37% |
Orbimed Advisors | 4,797,148 | $29,311,000 | 0.30% |
RA Capital Management | 2,731,170 | $16,687,000 | 0.27% |
J. Goldman & Co LP | 720,877 | $4,405,000 | 0.17% |
DAFNA Capital Management LLC | 38,891 | $238,000 | 0.05% |
BOOTHBAY FUND MANAGEMENT, LLC | 124,827 | $763,000 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 102,200 | $624,000 | 0.01% |